The Insulin Paradox: How GLP-1 Drugs Reduce Belly Fat and Heart Risk
GLP-1 drugs paradoxically reduce belly fat and heart risk by improving insulin timing and reducing chronic exposure, leading to visceral fat loss and better glucose control. Patient cases demonstrate these benefits.